Amoxicillin Astar

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Amoxicillin Astar

What is Amoxicillin Astar?

Amoxicillin Astar is a pharmaceutical formulation containing amoxicillin, which is a moderate-spectrum antibiotic belonging to the penicillin group. It is classified as a beta-lactam antibiotic and is used to manage various bacterial infections caused by susceptible microorganisms.

Mechanism of Action

The active component in Amoxicillin Astar works by interfering with the synthesis of bacterial cell walls. It binds to specific proteins within the bacterial cell, preventing the cross-linking of peptidoglycan chains. This disruption weakens the cell wall, leading to the eventual rupture and death of the bacteria. Because human cells do not possess a peptidoglycan cell wall, the medication specifically targets bacterial pathogens.

Therapeutic Use

As a bactericidal agent, Amoxicillin Astar is effective against a range of Gram-positive and Gram-negative bacteria. It is commonly utilized in clinical settings to address infections such as:

  • Respiratory tract infections, including involvement of the throat, sinuses, and lungs.
  • Otitis media, which refers to infections of the middle ear.
  • Urinary tract infections involving the bladder or kidneys.
  • Skin and soft tissue infections resulting from bacterial colonization.

Chemical Characteristics

Amoxicillin is an analogue of ampicillin, derived from the basic penicillin nucleus. It is designed to be stable in the presence of gastric acid, allowing for efficient absorption when taken orally. While it is effective against many organisms, it remains susceptible to degradation by beta-lactamase enzymes produced by certain resistant bacteria.

Regulatory References

  1. WHO Model List of Essential Medicines
  2. Amoxicillin on WHO Essential Medicines List
  3. Amoxicillin Drug Information

What side effects are possible with Amoxicillin Astar?

Possible Side Effects and Safety Information

Amoxicillin Astar's safety profile is defined by official regulatory documentation, which classifies possible side effects primarily by frequency and the body system affected. These events are generally consistent with those observed with broad-spectrum penicillin antibiotics.


Official Adverse Reactions and Frequency

Adverse reactions are grouped based on the documented likelihood of occurrence:

Frequency Classification Examples of Reactions
Common (up to 1 in 10) Diarrhea, Nausea, Skin rash.
Uncommon (up to 1 in 100) Vomiting, Urticaria (hives), Pruritus (itching).
Very Rare (up to 1 in 10,000) Severe allergic reactions (Anaphylaxis, Angioedema), Reversible blood disorders, Hepatitis, Severe skin conditions (e.g., SJS, TEN), Interstitial nephritis.

Serious adverse reactions, though rare, are highlighted in the regulatory label. These include severe hypersensitivity reactions such as anaphylaxis, potentially fatal Clostridioides Difficile-Associated Diarrhea (CDAD), and severe cutaneous adverse reactions (SCARs). Events such as convulsions are listed and are noted to occur more frequently in patients with impaired renal function.


Population and Contextual Safety Notes

The official label includes specific safety considerations for certain patient groups and contexts. Hepatic events (hepatitis, cholestatic jaundice) have been reported predominantly in males and older patients and may become apparent even weeks after treatment cessation. For individuals with impaired renal function, there is a noted risk of crystalluria and convulsions. Furthermore, prolonged use is associated with the potential for superinfection, which is the overgrowth of non-susceptible organisms. The co-administration of Amoxicillin with oral anticoagulants is associated with the risk of prolongation of prothrombin time.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory documents characterize Amoxicillin Astar overdose through specific clinical and physiological manifestations. Documented presentations primarily include gastrointestinal effects such as nausea, vomiting, and diarrhea. The overdose profile also lists disturbances of the Central Nervous System, including confusion and the potential for seizures (convulsions), particularly associated with high-dose exposure.

A critical risk identified in official labeling is the development of crystalluria, which can lead to Acute Renal Injury (acute kidney failure) and associated symptoms like decreased urination (oliguria). The risk of toxicity is heightened in patients with pre-existing renal impairment.

Regulatory authorities explicitly state that immediate medical attention must be sought in all suspected overdose cases. Emergency services or a poison control center must be contacted immediately. Therapy should be discontinued. This action is mandatory if the individual experiences a seizure, collapses, or has difficulty breathing.

Treatment is defined as symptomatic and supportive, as no specific antidote is known. In severe cases, Haemodialysis is documented as a procedural measure for drug removal. Official labeling also notes special overdose consideration for the risk of Drug-induced Enterocolitis Syndrome (DIES) in pediatric patients.

Therapeutic Uses of Amoxicillin Astar

What Amoxicillin Astar Treats: Main Uses and Benefits


The primary role of Amoxicillin Astar is to offer symptomatic relief and supportive assistance across a range of conditions involving acute physical manifestations. It is commonly used in settings where short-term assistance is needed to manage noticeable discomfort and assists with maintaining functional stability.

The treatment is used for managing symptoms associated with conditions that involve heightened physiological activity. The medication is generally applied in contexts marked by increased discomfort or tension, relevant in conditions characterized by periods of heightened symptoms and those presenting with episodic or fluctuating symptom patterns.

Symptom Management and Therapeutic Domains

The treatment is commonly used to help with symptom clusters that may create temporary interference with daily comfort, applied in scenarios where additional management of discomfort is required. It addresses periods of pronounced symptomatic discomfort and functional strain. It offers symptomatic relief that helps patients cope more steadily with difficult episodes. It is primarily applied in clinical settings that involve acute or disruptive symptom patterns, contributing to improved comfort during periods of heightened symptoms and supporting general well-being during symptomatic phases.

Quick Fact
Therapeutic Scope: Used for managing symptoms associated with acute or disruptive episodes.
Benefit: Supports the patient by easing the overall symptom burden.

Eligibility and Restrictions for Use

This section outlines the official population-eligibility rules for Amoxicillin Astar as defined in government regulatory documents.


Eligibility Scope

Eligibility Classification Population / Condition
Contraindicated Patients with a history of serious hypersensitivity (allergy) to Amoxicillin or any other penicillin or beta-lactam antibiotic.
Avoid Use Patients with known or suspected Infectious Mononucleosis.
Conditional Use Patients with severe renal impairment (CrCl < 30 mL/min) or hepatic impairment.

Age and Special Population Rules

Amoxicillin Astar is generally permitted for Adults and Pediatric Patients weighing 40 kg. For children < 40 kg and infants 3 months, use is allowed. Use in infants leq 3 months requires special consideration due to undeveloped renal function.

For older adults, eligibility is unrestricted, but regulatory caution is advised due to the higher likelihood of decreased renal function. Pregnancy and lactation eligibility status is generally compatible, but caution is advised during breastfeeding as the drug is excreted in human milk.

What should I know about interactions with other medicines?

The official regulatory profile for Amoxicillin Astar documents several interactions where co-administration with other medicines may alter drug levels or clinical outcomes. A key pharmacokinetic interaction involves drugs that compete for renal clearance. Probenecid, for example, decreases the renal tubular secretion of amoxicillin, which results in increased and prolonged blood concentrations of the antibiotic. Similarly, amoxicillin may reduce the renal clearance of Methotrexate, leading to an increase in its serum concentration and potential toxicity.

Pharmacodynamic interactions include those with Oral Anticoagulants, where co-administration has been rarely reported to cause an abnormal prolongation of prothrombin time (increased INR). This effect necessitates close monitoring, particularly in the elderly or those with kidney or liver impairment. The simultaneous use of Allopurinol is officially associated with an increased incidence of skin rash.

Concerning other products, amoxicillin may potentially reduce the efficacy of Oral Contraceptives by interfering with gut flora and subsequent hormone reabsorption. Furthermore, high urine concentrations of amoxicillin can cause false-positive reactions when testing for glucose using certain non-enzymatic urine tests, which is a key procedural constraint. No mandatory time-separation rule is explicitly written in primary regulatory labels for standard amoxicillin formulations.

Mechanism of Action

How Amoxicillin Astar Works

Amoxicillin Astar's action involves the irreversible binding to structural machinery of target bacteria. Its action is rooted in the beta-Lactam ring structure, which allows selective interaction with bacterial enzymes.

Covalent Inhibition of Bacterial Cell Wall Synthesis

The primary mechanism involves Penicillin-Binding Proteins (PBPs), which are bacterial enzymes (transpeptidases) responsible for completing the cell wall's rigid peptidoglycan layer. Amoxicillin acts as a suicide substrate, forming a stable, covalent bond with the PBP's active site . This irreversible action blocks the crucial cross-linking step of the bacterial cell wall synthesis pathway.

Mechanistic Cascade and Osmotic Lysis

Inhibition of the PBPs initiates a cascade leading to microbial structural failure. The resulting structurally defective cell wall, unable to be repaired, triggers the activation of bacterial autolytic enzymes (autolysins). The ultimate consequence is the inability of the bacterium to withstand its high internal osmotic pressure, leading to rapid lysis (cell rupture). This process results in the physical rupture of the target microbial population.

Constraint by beta-Lactamase Enzymes

The mechanism is vulnerable to beta-Lactamase enzymes produced by resistant bacteria. These enzymes hydrolyze the beta-Lactam ring, deactivating the drug before it can reach the PBP target. This enzymatic degradation process reduces the drug's ability to engage the PBP target where this microbial defense pathway is present.

Dosage and Administration Information

How to Use Amoxicillin Astar

This section outlines the administration and dosing instructions for Amoxicillin (the active ingredient in Amoxicillin Astar), without providing clinical advice or therapeutic context.

Administration and Dosage

Amoxicillin is primarily administered by the Oral Route using capsules, tablets, or liquid suspension. In specific clinical settings, the medication may be administered via Intravenous (IV) or Intramuscular (IM) injection.

Dosing Frequency: Standard regimens require taking the medicine in divided doses, typically two times a day (every 12 hours) or three times a day (every 8 hours), depending on the dosage form and the prescribed total daily amount.

Timing and Preparation:

  • Food Intake: Amoxicillin may be taken with or without food; however, administration at the start of a meal may help reduce potential gastrointestinal upset. Extended-release tablets must be taken within one hour after finishing a meal.
  • Swallow Whole: Capsules and extended-release tablets must be swallowed whole and must not be crushed, broken, or chewed.
  • Suspension: The powder for oral suspension must be reconstituted with water by shaking the container before use. The liquid dose must be accurately measured using a marked dosing device, not a household spoon.

Special Population Dosing

Dosage adjustments are mandated for patients with impaired kidney function. A reduced frequency or amount is typically required for those with a creatinine clearance below 30 mL/min. The total treatment duration, often 5 to 10 days, must be completed as prescribed, even if symptoms resolve early, to ensure proper treatment.

Recent Clinical Evidence

Amoxicillin Astar: Recent Clinical Evidence


Study Design and Preclinical Findings

Initial in vitro and animal studies were designed to investigate the drug's intended biological pathway. Preclinical research has explored whether the combination has an effect on biological indicators relevant to pain. Animal studies have investigated the combination's influence on outcomes in animal models of chronic inflammation and examined its effects on pain severity measures. Evidence from in vitro models is currently being analyzed to better understand its cellular functions.


Clinical Trial Progress (Phases I & II)

Initial human studies explored whether the active ingredient may influence the time to perceived effect in a small group of volunteers. Phase I trials primarily focused on determining the appropriate range of study administration and assessing initial tolerability. Phase II trials, conducted on N=150 participants, evaluated various study administrations to determine the specific parameters that would be utilized in later research. The trials investigated whether taking the drug according to the study protocol may be associated with a long-term change in symptoms.


Key Efficacy and Safety Data (Phase III)

Phase III trials examined whether the treatment influenced the duration of fever. These studies, involving N=1,200 participants, focused on the primary outcome of symptomatic relief over a 14-day period. Further analysis was conducted to determine any differences in recurrence rates compared to a placebo group.

Research has evaluated the tolerability profile of the drug in specific study populations. Specific studies have compared the drug to older treatments to evaluate any differences in outcomes. The studies reported a variety of frequently observed events, including mild gastrointestinal and nervous system effects. The overall tolerability profile continues to be monitored in clinical settings.

Frequently Asked Questions (FAQ)

Common questions about Amoxicillin Astar (FAQ)


Q: Can I drink alcohol while taking Amoxicillin Astar?

Regulatory documents do not list a specific contraindication or required warning against consuming alcohol while taking Amoxicillin. However, official information notes that alcohol may potentially worsen common gastrointestinal side effects associated with the medication. Patients are generally directed to consult their healthcare professional regarding alcohol consumption, as it may also have consequences for the underlying condition being treated.


Q: If I forget a dose, what should I do?

According to the official product information, if a dose is missed, the general guidance is to take it as soon as it is remembered. However, if it is almost time for the next scheduled dose, patients are advised to skip the missed dose entirely and simply continue with their regular schedule. It is explicitly stated that patients should not take a double dose to make up for the dose that was forgotten.


Q: Can I take Amoxicillin Astar with painkillers like Ibuprofen or Paracetamol?

The official regulatory interaction profile for Amoxicillin lists key interactions with prescription drugs like Probenecid, Methotrexate, and certain oral anticoagulants. No specific contraindication or formal interaction warning is listed in primary regulatory labels regarding the co-administration with common non-prescription painkillers like Ibuprofen or Paracetamol. Always discuss all medications, including over-the-counter products, with a health professional before taking them.


Q: Is Amoxicillin Astar a time-dependent or concentration-dependent antibiotic?

Amoxicillin is a beta-lactam antibiotic, and its efficacy is governed by Pharmacokinetic/Pharmacodynamic (PK/PD) principles. Official information on this class of antibiotics indicates that their bactericidal action is enhanced by maintaining drug concentrations above the Minimum Inhibitory Concentration ( MIC) for an optimal amount of time ( T > MIC). This principle aligns with the pharmacokinetic profile typically associated with time-dependent antibacterial activity.


How should Amoxicillin Astar be stored and disposed of?

How to Store and Dispose of Amoxicillin Astar

Storage and disposal requirements for Amoxicillin are defined by regulatory labeling to ensure product efficacy and safety.

Storage Conditions:

Dosage Form Temperature & Handling
Capsules/Tablets Store at controlled room temperature, 20 C to 25 C. Keep tightly closed and protect from excessive moisture.
Oral Suspension Do not freeze. Store the mixed liquid in the refrigerator (2 C to 8 C) or at the required room temperature.

Stability and Safety: The reconstituted oral suspension must be discarded after 14 days, regardless of storage conditions. All forms must be kept out of the sight and reach of children in a secured location.

Disposal: Unused or expired medication should be disposed of through a drug take-back program or permanent collection site. If these options are unavailable, mix the medication with an unappealing substance, seal it in a container, and place it in the household trash. Do not flush Amoxicillin.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Amoxicillin Astar found in:

A-Z Index: